Developer docs
API playgroundTry for free, no card

Search company profiles

Medscint

Full company profile

uuid0004snq

Namestring
Medscint
Legal namestring
Medscint
Websiteurl
medscint.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Medscint is a Quebec-based medical device company founded in 2018 that develops plastic scintillation dosimetry solutions for radiotherapy quality assurance. Its core technology is a proprietary hyperspectral scintillation dosimetry approach that differentiates between scintillation and Cherenkov emissions, enabling Cherenkov-free, real-time, multi-point dose measurements without stem-effect interference. The company's product architecture is anchored on the HYPERSCINT platform, comprising the HYPERSCINT QA medical device (the company's first commercially distributed medical device, available in the US, Japan, and South Korea), the HYPERSCINT RP-200 research platform for time-resolved dosimetry in adaptive radiotherapy and MR-LINAC settings, and the HYPERSCINT RP-FLASH for ultra-high dose-rate (FLASH) applications. These are complemented by a modular detector family (PRO, MICRO, FLEX, FLASH, MODULES) supporting specialized use cases such as sub-millimeter small fields, in-catheter measurements, and integration with the IBA QUASAR MRI4D Motion Phantom for MR-guided radiotherapy QA.

The company sells hardware directly to clinical and research customers through enterprise sales and contact-driven engagement, complemented by regional distribution partnerships covering South Korea (EnergyFlow), Italy (DosimETrICA), Spain (Fimecorp), BENELUX (Radicare), and the UK/general (OSL). Pricing is quote-based and not publicly disclosed. Customer segments are primarily clinical medical physicists at hospitals and academic medical centers conducting advanced radiotherapy research, with a secondary segment of FLASH and proton therapy research groups. As of late 2025, Medscint reports HYPERSCINT solutions deployed across 15 countries, with named customers spanning academic institutions (University of Maryland, UC Davis, University of Victoria, University of Galway) and hospital systems (CHU de Québec–Université Laval, Odense University Hospital, Hôpital général juif). The company employs approximately 12 team members led by co-founder François Therriault-Proulx, with deep in-house technical depth across medical physics, optical engineering, and software development, supported by strategic R&D and clinical partnerships with Université Laval and CHU de Québec.

Short descriptiontext

Medscint is a Quebec-based medical device company developing plastic scintillation dosimetry systems (HYPERSCINT platform) for real-time radiotherapy quality assurance, serving clinical medical physicists and radiation oncology researchers across 15 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersQuebec, Canada
HQ citystring
Quebec
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiotherapy dosimetry, plastic scintillation detectors, radiation quality assurance, FLASH radiotherapy dosimetry, medical physics equipment
Industry2 codes
1Interventional Radiology & Image-Guided Therapy Systems
CodeHLAHABAGPrimaryYes
2Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
CodeHLACALALPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Laboratory Analytical Instruments3826
Product category
Radiotherapy Dosimetry Equipment
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales (HYPERSCINT QA)
TypeHardware Sales
Description

Sale of HYPERSCINT QA medical device for radiotherapy quality assurance in clinical settings. Commercial distribution in US, Japan, and South Korea.

medscint.com
2Research Platform Sales (HYPERSCINT RP-200 and RP-FLASH)
TypeHardware Sales
Description

Sale of research-grade dosimetry platforms and accessories for research institutions. Available for research purpose distribution globally.

medscint.com
3Custom Detector Solutions
TypeHardware Sales
Description

Customized detectors aligned with specific research requirements, offering modular platform solutions for specialized applications.

medscint.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Marketing or Sales, Supply Chain, Personnel, Operations
Pricing details1 tier
1Quote-based pricing for HYPERSCINT QA system
ModelOtherBilling cadenceMulti-year contract
Notes

HYPERSCINT QA system pricing requires direct contact. Contact form available on website for quotes.

medscint.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Medscint designs, manufactures, and sells plastic scintillation dosimetry systems for radiotherapy quality assurance. Its flagship HYPERSCINT QA is a 2-channel medical device for clinical small-field dosimetry and End-to-End QA, commercially distributed in the United States, Japan, and South Korea. The HYPERSCINT Research Platform (RP-200 and RP-FLASH variants) provides turnkey, real-time, multi-point dosimetry for advanced radiotherapy research including MR-LINAC, Adaptive-RT, and FLASH (Ultra-High Dose-Rate) applications. The portfolio is complemented by a modular detector series (PRO, MICRO, FLEX, FLASH, MODULES) and the HYPERDOSE QA Software for real-time visualization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Near-unity correction factors (1.002 to 0.999) across field sizes between 0.6×0.6 cm² and 30×30 cm² with 0.5% total uncertainty
+2 more records
Product overview1 text field

Medscint is a Quebec-based manufacturer of medical radiation therapy devices and a leader in plastic scintillation dosimetry solutions. The company offers a platform-plus-products architecture anchored by the HYPERSCINT technology platform, which uses proprietary hyperspectral technology combined with plastic scintillators, optics, and photonic systems. The core product family includes HYPERSCINT QA (medical device for clinical use), HYPERSCINT RP-200 (research platform for advanced applications), and HYPERSCINT RP-FLASH (specialized for FLASH/UHDR radiotherapy). These are complemented by modular detector series (PRO, MICRO, FLEX, FLASH, MODULES) that provide specialized capabilities for different measurement scenarios. The platform provides water-equivalent, MRI-safe, energy-independent, angle-independent, dose rate-independent, real-time, multi-point dosimetry for quality assurance in radiotherapy.

Product and service8 records
1HYPERSCINT QA
CategoryClinical Radiotherapy QA Medical Device
Description

A medical device providing next-generation dosimetry quality assurance for radiotherapy. Features a compact water-equivalent 2-channel plastic scintillation detector (Radius 0.5mm, Length 1mm, Volume 0.785mm³) for accurate photon and electron dose measurements across small and large field sizes. Designed for clinical medical physicists performing radiotherapy QA in hospitals. Available for commercial distribution in the United States, Japan, and South Korea.

2HYPERSCINT RP-200
CategoryResearch-Grade Dosimetry Platform
Description

A real-time, multi-point-ready, and versatile turnkey dosimetry tool leveraging plastic scintillators for time-resolved dosimetry of motion/gated applications (e.g., Adaptive-RT, MR-LINAC), small fields, and multi-met End-to-End testing. Designed for medical physics researchers at academic institutions and hospitals conducting advanced radiotherapy research. Available for commercial distribution worldwide for research purposes.

3HYPERSCINT RP-FLASH
CategoryFLASH / UHDR Research Dosimetry Platform
Description

A second-generation Ultra-High-Speed Plastic Scintillation Dosimetry Solution designed for FLASH (Ultra-High Dose-Rate/UHDR) radiotherapy applications. Once calibrated at conventional dose-rate, it precisely measures dose-per-pulse, average dose-rate, and integrated dose for QA of FLASH irradiators. Designed for advanced radiotherapy research groups. Available for research purposes worldwide.

4PRO Series Scintillation Detector (1CH / 2CH / 4CH)
CategoryModular Scintillation Detector
Description

High-precision scintillation detectors with a sharp 1mm² active area, waterproof design for multiple QA setups. Supports simultaneous single (1CH) or multi-point (2CH or 4CH) real-time dose measurements for End-to-End validation and Adaptive-RT QA. Designed for clinical medical physicists and researchers.

5MICRO Series Detector
CategoryModular Scintillation Detector
Description

Ultra-small scintillator (0.5x0.5mm) for best precision in ultra-small fields thanks to ultra-low volume averaging. Designed for field sizes below 5mm including mini beams and spatially fractionated radiotherapy (SFRT). Targeted at advanced radiotherapy researchers.

6FLEX Series Detector
CategoryModular Scintillation Detector
Description

Flexible scintillation detector design for measurements in restricted areas such as catheters or small animal phantoms. One model fits within 6FR catheters; another more rigid model fits within 2mm openings. Targeted at specialized research and clinical applications including brachytherapy and small animal irradiators.

7FLASH Series Detector
CategoryModular Scintillation Detector
Description

Radiation-hard scintillation detector engineered for Ultra-High Dose-Rate (UHDR) applications. Capable of measuring dose per pulse, average dose-rate, and integrated dose simultaneously. Designed for FLASH radiotherapy research groups.

8MODULES Series Scintillation Detector
CategoryModular Scintillation Detector / Integrated Cassette
Description

Fully integrated scintillation detector (single or multiple points) for real-time and seamless performances in advanced setups such as adaptive radiotherapy. Includes the MRI4D Scintillation Detector Cassette with 4 PRO Series scintillators compatible with IBA QUASAR MRI4D Motion Phantom for MR-guided radiotherapy QA and latency measurements on Elekta Unity MR-Linac systems.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-10-09
Description

Selected among seven innovative startups to join program complementary to Stage V that supports high-potential companies in international growth.

Strategic tierStrategicTypeGTM or Marketing PartnerAnnounced on2025-01-22
Description

Membership in Mayo Clinic Innovation Exchange program that fosters breakthrough innovation by connecting healthcare entrepreneurs, startups, and experts.

Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-09-24
Description

Strategic distribution partnership for advanced radiotherapy QA solutions in South Korea. EnergyFlow is an independent provider of solutions and consultancy services.

Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-09-10
Description

Distribution partnership for innovative radiotherapy QA solutions in Italy. DosimETrICA is a renowned independent supplier of dosimetry tools and consultancy in Radiotherapy, Radiology, and Medical Physics.

Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-05-09
Description

Distribution agreement for plastic scintillation quality assurance equipment in Spain. Fimecorp is a major and trusted independent provider of medical equipment and software.

Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-05-02
Description

Distribution partnership for plastic scintillation dosimetry solutions in BENELUX region (Belgium, Netherlands, Luxembourg).

Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-07-25
Description

Distribution agreement for plastic scintillation quality assurance equipment. OSL is a major and trusted independent provider of medical equipment and software to the radiotherapy community.

Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2021-06-15
Description

U.S. Go-to-Market program to help Medscint expand into the US market. Part of inaugural cohort of 10 medical device and digital health companies selected from nearly 30 applicants.

Strategic tierCoreTypeTechnology or Integration
Description

Collaboration on MRI4D Scintillation Detector Cassette integrating 4 Medscint scintillators compatible with IBA QUASAR MRI4D Motion Phantom for MRgRT QA.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership with Université Laval through which many team members are trained and multiple research collaborations are conducted. Founding scientific community behind the technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major research and clinical partnership. CHU de Québec team members collaborate on product development and serve as key beta testing site.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

RTI Group (Sweden) manufactures X-ray QA meters, multimeters, and detectors for radiology and radiotherapy QA. Comparable in size and product category to Medscint, with a similar focus on real-time, multi-purpose measurement hardware.

TypeDirect peer
Description

Modus Medical Devices manufactures QA phantoms and devices (such as the QUASAR MRI4D Motion Phantom) used in radiotherapy, with which Medscint's MRI4D scintillation cassette integrates. Direct peer in radiotherapy QA tooling and a channel/integration partner rather than a head-to-head substitute in scintillation.

TypeDirect peer
Description

Capintec manufactures radiation measurement and dose calibrator equipment, including ionization chambers and nuclear medicine instrumentation. Overlaps with Medscint on detector-based measurement devices sold into radiation medicine end markets.

TypeDirect peer
Description

Standard Imaging (now part of PTW Dosimetry) designs and manufactures QA instruments and phantoms for radiotherapy, including electrometers, ion chambers, and the daily QA portfolio used at linac consoles. Directly comparable to Medscint's radiotherapy QA offering for clinical centers.

TypeDirect peer
Description

PTW is the global leader in radiation dosimetry, manufacturing ionization chambers, diamond detectors, and reference-class QA equipment used in radiotherapy and radiology. It is Medscint's most direct and largest competitor across clinical dosimetry product lines.

TypeDirect peer
Description

IBA Dosimetry is a major vendor of dosimetry equipment for radiation therapy and radiology, including ionization chambers, detectors, and QA software. Notable here because IBA's QUASAR MRI4D Motion Phantom is a current Medscint integration partner, evidencing its position as a comparable physical-phantom and QA vendor.

TypeDirect peer
Description

Sun Nuclear (now under Mirion) supplies patient QA hardware, phantoms, and software for radiotherapy and diagnostic imaging - including the IC Profiler, MapCHECK, and PerFRACTION portfolios. A direct peer in radiotherapy QA, now operating with Mirion's broader radiation detection scale.

8CIRS (Computerized Imaging Reference Systems)
TypeDirect peer
Description

CIRS designs tissue-equivalent phantoms and QA products for radiology and radiotherapy, used for dose verification, image quality, and end-to-end testing. Direct peer in physical QA tooling for radiation therapy and a relevant point of comparison for end-to-end QA workflow positioning.

TypeBroad incumbent
Description

Fluke Biomedical (now part of Fluke Health Solutions) provides broad biomedical and radiation QA equipment including dosimeters and survey meters. A broader incumbent with a wide QA portfolio that overlaps with Medscint's radiotherapy QA category but does not specifically target scintillation-based small-field dosimetry.

TypeDirect peer
Description

Best Medical manufactures QA devices for external beam therapy, brachytherapy, and IMRT, including ionization chambers, phantoms, and detector arrays. Direct peer in clinical radiotherapy dosimetry hardware with overlapping hospital customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medscint

Radiotherapy Dosimetry Equipmentmedscint.com

Medscint is a Quebec-based medical device company developing plastic scintillation dosimetry systems (HYPERSCINT platform) for real-time radiotherapy quality assurance, serving clinical medical physicists and radiation oncology researchers across 15 countries.

What Medscint does

Medscint is a Quebec-based medical device company founded in 2018 that develops plastic scintillation dosimetry solutions for radiotherapy quality assurance. Its core technology is a proprietary hyperspectral scintillation dosimetry approach that differentiates between scintillation and Cherenkov emissions, enabling Cherenkov-free, real-time, multi-point dose measurements without stem-effect interference. The company's product architecture is anchored on the HYPERSCINT platform, comprising the HYPERSCINT QA medical device (the company's first commercially distributed medical device, available in the US, Japan, and South Korea), the HYPERSCINT RP-200 research platform for time-resolved dosimetry in adaptive radiotherapy and MR-LINAC settings, and the HYPERSCINT RP-FLASH for ultra-high dose-rate (FLASH) applications. These are complemented by a modular detector family (PRO, MICRO, FLEX, FLASH, MODULES) supporting specialized use cases such as sub-millimeter small fields, in-catheter measurements, and integration with the IBA QUASAR MRI4D Motion Phantom for MR-guided radiotherapy QA.

The company sells hardware directly to clinical and research customers through enterprise sales and contact-driven engagement, complemented by regional distribution partnerships covering South Korea (EnergyFlow), Italy (DosimETrICA), Spain (Fimecorp), BENELUX (Radicare), and the UK/general (OSL). Pricing is quote-based and not publicly disclosed. Customer segments are primarily clinical medical physicists at hospitals and academic medical centers conducting advanced radiotherapy research, with a secondary segment of FLASH and proton therapy research groups. As of late 2025, Medscint reports HYPERSCINT solutions deployed across 15 countries, with named customers spanning academic institutions (University of Maryland, UC Davis, University of Victoria, University of Galway) and hospital systems (CHU de Québec–Université Laval, Odense University Hospital, Hôpital général juif). The company employs approximately 12 team members led by co-founder François Therriault-Proulx, with deep in-house technical depth across medical physics, optical engineering, and software development, supported by strategic R&D and clinical partnerships with Université Laval and CHU de Québec.

Medscint firmographics

Firmographics
Name
Medscint
Legal name
Medscint
Website
https://medscint.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Medscint is a Quebec-based medical device company developing plastic scintillation dosimetry systems (HYPERSCINT platform) for real-time radiotherapy quality assurance, serving clinical medical physicists and radiation oncology researchers across 15 countries.
Ownership category
akta.pro rank

Medscint industry classification

Industry
Product category
Radiotherapy Dosimetry Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
akta.pro secondary industry
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL)

Keywords

  • Radiotherapy dosimetry
  • Plastic scintillation detectors
  • Radiation quality assurance
  • FLASH radiotherapy dosimetry
  • Medical physics equipment

Where Medscint is headquartered

Location

Headquarters

HQ city
Quebec
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Medscint business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Marketing or Sales, Supply Chain, Personnel, Operations

Revenue model

  1. Medical Device Sales (HYPERSCINT QA): Sale of HYPERSCINT QA medical device for radiotherapy quality assurance in clinical settings. Commercial distribution in US, Japan, and South Korea.
  2. Research Platform Sales (HYPERSCINT RP-200 and RP-FLASH): Sale of research-grade dosimetry platforms and accessories for research institutions. Available for research purpose distribution globally.
  3. Custom Detector Solutions: Customized detectors aligned with specific research requirements, offering modular platform solutions for specialized applications.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for HYPERSCINT QA system

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Medscint product offering

Product offering

Core offering

Medscint designs, manufactures, and sells plastic scintillation dosimetry systems for radiotherapy quality assurance. Its flagship HYPERSCINT QA is a 2-channel medical device for clinical small-field dosimetry and End-to-End QA, commercially distributed in the United States, Japan, and South Korea. The HYPERSCINT Research Platform (RP-200 and RP-FLASH variants) provides turnkey, real-time, multi-point dosimetry for advanced radiotherapy research including MR-LINAC, Adaptive-RT, and FLASH (Ultra-High Dose-Rate) applications. The portfolio is complemented by a modular detector series (PRO, MICRO, FLEX, FLASH, MODULES) and the HYPERDOSE QA Software for real-time visualization.

Product overview

Medscint is a Quebec-based manufacturer of medical radiation therapy devices and a leader in plastic scintillation dosimetry solutions. The company offers a platform-plus-products architecture anchored by the HYPERSCINT technology platform, which uses proprietary hyperspectral technology combined with plastic scintillators, optics, and photonic systems. The core product family includes HYPERSCINT QA (medical device for clinical use), HYPERSCINT RP-200 (research platform for advanced applications), and HYPERSCINT RP-FLASH (specialized for FLASH/UHDR radiotherapy). These are complemented by modular detector series (PRO, MICRO, FLEX, FLASH, MODULES) that provide specialized capabilities for different measurement scenarios. The platform provides water-equivalent, MRI-safe, energy-independent, angle-independent, dose rate-independent, real-time, multi-point dosimetry for quality assurance in radiotherapy.

Differentiator

Problem solved

Functional benefit

Products and services

  • HYPERSCINT QA A medical device providing next-generation dosimetry quality assurance for radiotherapy. Features a compact water-equivalent 2-channel plastic scintillation detector (Radius 0.5mm, Length 1mm, Volume 0.785mm³) for accurate photon and electron dose measurements across small and large field sizes. Designed for clinical medical physicists performing radiotherapy QA in hospitals. Available for commercial distribution in the United States, Japan, and South Korea.
  • HYPERSCINT RP-200 A real-time, multi-point-ready, and versatile turnkey dosimetry tool leveraging plastic scintillators for time-resolved dosimetry of motion/gated applications (e.g., Adaptive-RT, MR-LINAC), small fields, and multi-met End-to-End testing. Designed for medical physics researchers at academic institutions and hospitals conducting advanced radiotherapy research. Available for commercial distribution worldwide for research purposes.
  • HYPERSCINT RP-FLASH A second-generation Ultra-High-Speed Plastic Scintillation Dosimetry Solution designed for FLASH (Ultra-High Dose-Rate/UHDR) radiotherapy applications. Once calibrated at conventional dose-rate, it precisely measures dose-per-pulse, average dose-rate, and integrated dose for QA of FLASH irradiators. Designed for advanced radiotherapy research groups. Available for research purposes worldwide.
  • PRO Series Scintillation Detector (1CH / 2CH / 4CH) High-precision scintillation detectors with a sharp 1mm² active area, waterproof design for multiple QA setups. Supports simultaneous single (1CH) or multi-point (2CH or 4CH) real-time dose measurements for End-to-End validation and Adaptive-RT QA. Designed for clinical medical physicists and researchers.
  • MICRO Series Detector Ultra-small scintillator (0.5x0.5mm) for best precision in ultra-small fields thanks to ultra-low volume averaging. Designed for field sizes below 5mm including mini beams and spatially fractionated radiotherapy (SFRT). Targeted at advanced radiotherapy researchers.
  • FLEX Series Detector Flexible scintillation detector design for measurements in restricted areas such as catheters or small animal phantoms. One model fits within 6FR catheters; another more rigid model fits within 2mm openings. Targeted at specialized research and clinical applications including brachytherapy and small animal irradiators.
  • FLASH Series Detector Radiation-hard scintillation detector engineered for Ultra-High Dose-Rate (UHDR) applications. Capable of measuring dose per pulse, average dose-rate, and integrated dose simultaneously. Designed for FLASH radiotherapy research groups.
  • MODULES Series Scintillation Detector Fully integrated scintillation detector (single or multiple points) for real-time and seamless performances in advanced setups such as adaptive radiotherapy. Includes the MRI4D Scintillation Detector Cassette with 4 PRO Series scintillators compatible with IBA QUASAR MRI4D Motion Phantom for MR-guided radiotherapy QA and latency measurements on Elekta Unity MR-Linac systems.

Quantifiable outcome

  • Near-unity correction factors (1.002 to 0.999) across field sizes between 0.6×0.6 cm² and 30×30 cm² with 0.5% total uncertainty
  • +2 more outcomes

Companies that use Medscint

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Medscint technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature9 records

Medscint partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered minor, strategic, regional and core.

  • Québec Tech Stage Vo ProgramminorGTM or Marketing Partner · 9 October 2025Selected among seven innovative startups to join program complementary to Stage V that supports high-potential companies in international growth.
  • Mayo Clinic Innovation ExchangestrategicGTM or Marketing Partner · 22 January 2025Membership in Mayo Clinic Innovation Exchange program that fosters breakthrough innovation by connecting healthcare entrepreneurs, startups, and experts.
  • EnergyFlow Inc.regionalChannel Partner/ Reseller/ Distributor · 24 September 2024Strategic distribution partnership for advanced radiotherapy QA solutions in South Korea. EnergyFlow is an independent provider of solutions and consultancy services.
  • DosimETrICAregionalChannel Partner/ Reseller/ Distributor · 10 September 2024Distribution partnership for innovative radiotherapy QA solutions in Italy. DosimETrICA is a renowned independent supplier of dosimetry tools and consultancy in Radiotherapy, Radiology, and Medical Physics.
  • Fimecorp International s.l.regionalChannel Partner/ Reseller/ Distributor · 9 May 2024Distribution agreement for plastic scintillation quality assurance equipment in Spain. Fimecorp is a major and trusted independent provider of medical equipment and software.
  • Radicare b.v.regionalChannel Partner/ Reseller/ Distributor · 2 May 2024Distribution partnership for plastic scintillation dosimetry solutions in BENELUX region (Belgium, Netherlands, Luxembourg).
  • Oncology Systems Limited (OSL)regionalChannel Partner/ Reseller/ Distributor · 25 July 2023Distribution agreement for plastic scintillation quality assurance equipment. OSL is a major and trusted independent provider of medical equipment and software to the radiotherapy community.
  • Medical Alley AssociationcoreGTM or Marketing Partner · 15 June 2021U.S. Go-to-Market program to help Medscint expand into the US market. Part of inaugural cohort of 10 medical device and digital health companies selected from nearly 30 applicants.
  • IBA QUASAR (Modus Medical Devices)coreTechnology or IntegrationCollaboration on MRI4D Scintillation Detector Cassette integrating 4 Medscint scintillators compatible with IBA QUASAR MRI4D Motion Phantom for MRgRT QA.
  • Université LavalcoreStrategic or Co-development PartnerAcademic partnership with Université Laval through which many team members are trained and multiple research collaborations are conducted. Founding scientific community behind the technology.
  • CHU de QuébeccoreStrategic or Co-development PartnerMajor research and clinical partnership. CHU de Québec team members collaborate on product development and serve as key beta testing site.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Medscint competitors and assessment

Company assessment

Direct peers

  • RTI Group: RTI Group (Sweden) manufactures X-ray QA meters, multimeters, and detectors for radiology and radiotherapy QA. Comparable in size and product category to Medscint, with a similar focus on real-time, multi-purpose measurement hardware.
  • Modus Medical Devices: Modus Medical Devices manufactures QA phantoms and devices (such as the QUASAR MRI4D Motion Phantom) used in radiotherapy, with which Medscint's MRI4D scintillation cassette integrates. Direct peer in radiotherapy QA tooling and a channel/integration partner rather than a head-to-head substitute in scintillation.
  • Capintec: Capintec manufactures radiation measurement and dose calibrator equipment, including ionization chambers and nuclear medicine instrumentation. Overlaps with Medscint on detector-based measurement devices sold into radiation medicine end markets.
  • Standard Imaging: Standard Imaging (now part of PTW Dosimetry) designs and manufactures QA instruments and phantoms for radiotherapy, including electrometers, ion chambers, and the daily QA portfolio used at linac consoles. Directly comparable to Medscint's radiotherapy QA offering for clinical centers.
  • PTW Freiburg: PTW is the global leader in radiation dosimetry, manufacturing ionization chambers, diamond detectors, and reference-class QA equipment used in radiotherapy and radiology. It is Medscint's most direct and largest competitor across clinical dosimetry product lines.
  • IBA Dosimetry: IBA Dosimetry is a major vendor of dosimetry equipment for radiation therapy and radiology, including ionization chambers, detectors, and QA software. Notable here because IBA's QUASAR MRI4D Motion Phantom is a current Medscint integration partner, evidencing its position as a comparable physical-phantom and QA vendor.
  • Sun Nuclear (Mirion Technologies): Sun Nuclear (now under Mirion) supplies patient QA hardware, phantoms, and software for radiotherapy and diagnostic imaging - including the IC Profiler, MapCHECK, and PerFRACTION portfolios. A direct peer in radiotherapy QA, now operating with Mirion's broader radiation detection scale.
  • CIRS (Computerized Imaging Reference Systems): CIRS designs tissue-equivalent phantoms and QA products for radiology and radiotherapy, used for dose verification, image quality, and end-to-end testing. Direct peer in physical QA tooling for radiation therapy and a relevant point of comparison for end-to-end QA workflow positioning.
  • Best Medical (CIVCO): Best Medical manufactures QA devices for external beam therapy, brachytherapy, and IMRT, including ionization chambers, phantoms, and detector arrays. Direct peer in clinical radiotherapy dosimetry hardware with overlapping hospital customer base.

Broad incumbents

  • Fluke Health Solutions (Radiation Detection): Fluke Biomedical (now part of Fluke Health Solutions) provides broad biomedical and radiation QA equipment including dosimeters and survey meters. A broader incumbent with a wide QA portfolio that overlaps with Medscint's radiotherapy QA category but does not specifically target scintillation-based small-field dosimetry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Medscint social profiles

Digital presence

Medscint financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medscint leadership team

Management profile

Number of profiles

Profiles12 records

Medscint funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medscint M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medscint

What does Medscint do?

Medscint designs, manufactures, and sells plastic scintillation dosimetry systems for radiotherapy quality assurance. Its flagship HYPERSCINT QA is a 2-channel medical device for clinical small-field dosimetry and End-to-End QA, commercially distributed in the United States, Japan, and South Korea. The HYPERSCINT Research Platform (RP-200 and RP-FLASH variants) provides turnkey, real-time, multi-point dosimetry for advanced radiotherapy research including MR-LINAC, Adaptive-RT, and FLASH (Ultra-High Dose-Rate) applications. The portfolio is complemented by a modular detector series (PRO, MICRO, FLEX, FLASH, MODULES) and the HYPERDOSE QA Software for real-time visualization.

Is Medscint a public or private company?

Medscint is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Medscint founded?

Medscint was founded in 2018. It employs 1 to 10 people.

Where is Medscint based?

Medscint is headquartered in Quebec, Canada, in the North America region.

How does Medscint make money?

Three revenue lines are on record. Medical Device Sales (HYPERSCINT QA) is the primary driver. The others are research Platform Sales (HYPERSCINT RP-200 and RP-FLASH) and custom Detector Solutions.

Who are Medscint's main competitors?

Direct peers on record are RTI Group, Modus Medical Devices, Capintec, Standard Imaging, PTW Freiburg, IBA Dosimetry, Sun Nuclear (Mirion Technologies), CIRS (Computerized Imaging Reference Systems) and Best Medical (CIVCO). Fluke Health Solutions (Radiation Detection) is listed as a broad incumbent.

Does Medscint have an API?

No public API is recorded for Medscint.

What industry is Medscint in?

Medscint's product category is Radiotherapy Dosimetry Equipment. Its primary akta.pro industry code is HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems, with a secondary code of HLACALAL, Quality, Peer Review & Compliance Tools (MQSA/ACR/QA). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsCanada Invests $400K in Medscint, Boosts EconomyThe Government of Canada, through its Canada Economic Development for Quebec Regions (CED) agency, announced a $400,000 repayable contribution to Medscint, a Quebec-based medical device company specializing in radiation therapy technology. The funding will enable Medscint to develop an optimized marketing strategy and adapt its optical dosimetry products for new international target markets. This investment forms part of Canada's broader strategy to strengthen manufacturing sector resilience and support homegrown businesses in integrating into Canadian value chains.NewswireHomegrown manufacturers at the heart of Canada's economy: Government of Canada invests $400,000 in MedscintThe Government of Canada, through Canada Economic Development for Quebec Regions (CED), announced a $400,000 repayable contribution to Medscint, a Quebec-based medical device manufacturer specializing in radiation therapy products. The funding, granted under CED's Regional Economic Growth through Innovation program, will enable Medscint to develop an optimized marketing strategy and adapt its products for new target markets to support international growth. This investment reflects the government's broader plan to strengthen the resilience and competitiveness of Canadian manufacturing businesses and promote homegrown innovation in strategic sectors.Canada.caHomegrown manufacturers at the heart of Canada’s economy: Government of Canada invests $400,000 in MedscintCanada Economic Development for Quebec Regions (CED) announced a $400,000 repayable contribution to Medscint, a Quebec-based medical device manufacturer specializing in radiation therapy technology. The funding will support Medscint in developing an optimized marketing strategy and adapting its products for new international target markets. This investment is part of Canada's broader plan to strengthen manufacturing competitiveness and support homegrown businesses in integrating into Canadian value chains.